期刊文献+

锶元素促成骨机制及在口腔再生医学中的应用研究进展 被引量:1

Research progress on the mechanism of strontium promoting bone formation and its application in oral regenerative medicine
在线阅读 下载PDF
导出
摘要 口腔再生医学是近年发展起来的一门新兴学科,它将再生医学的基本理论和方法引入口腔医学领域,研究口腔颌面部各种组织器官的正常组织特征与功能以及创伤修复与再生机制,以改善或恢复病损口腔组织和器官的结构与功能,已成为当前口腔科学领域发展最快的交叉学科。锶为人体的必需微量元素,与多种生理功能有关,可用作骨质疏松症的预防性治疗;锶离子的释放对于预防破骨细胞活化和促进成骨细胞分化具有直接作用,也在组织免疫方面发挥着重要作用,能够促进骨骼的生长发育,已成为口腔再生领域的研究热点。本文结合锶元素对生物材料性能的改变,分析现有问题,对锶元素促成骨机制及其在口腔再生医学中的应用进行综述。 Oral regenerative medicine is a new discipline developed in recent years.It introduces the basic theories and methods of regenerative medicine into the field of stomatology to explore the normal tissue characteristics and functions of various tissues and organs in oral and maxillofacial region and the mechanism of wound repair and regeneration,so as to improve or restore the structure and function of damaged oral tissues and organs.It has become the fastest-growing interdisciplinary subject in the field of stomatology.Strontium is an essential trace element in human body,which is related to many physiological functions and can be used as a preventive treatment for osteoporosis.The release of strontium ions plays a direct role in preventing osteoclast activation and promoting osteoblast differentiation,also plays an important role in tissue immunity,and promotes bone growth and development.Therefore,it has become a research hotspot in the field of oral regeneration.This paper analyzes the existing problems in combination with the changes of strontium on the properties of biomaterials,and summarize the mechanism of strontium promoting bone formation and its application in oral regenerative medicine.
作者 董昕玥 张晓明 刘念 马向瑞 DONG Xinyue;ZHANG Xiaoming;LIU Nian;MA Xiangrui(Department of Prosthodontics,Binzhou Medical University Hospital,Shandong,Binzhou 256600,China)
出处 《中国医药科学》 2024年第3期37-40,共4页 China Medicine And Pharmacy
基金 山东省自然科学基金(ZR2018BH026)。
关键词 骨缺损 骨结合 骨再生 牙周 Strontium Bone defect Osseointegration Bone regeneration Periodontal
  • 相关文献

参考文献4

二级参考文献39

  • 1Garnero P, Detmas PD, Bilezikian JP. Evaluation of risk for osteo- porosis fractures. Principles of Bone Biology 2002; 1291-301.
  • 2Naot D, Grey A, Reid IR, Cornish J. Lactoferrin - a novel bone growth factor. Clin Med Res 2005; 5: 93-101.
  • 3Omi N, Ezawa I. The effect of ovariectomy on bone metabolism in rats. Bone 1995; 17: 163S-168S.
  • 4Metz-Boutigue MH, Jolles J, Mazurier J, Schoentgen F, Legrand D, Spik G, et al. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur J Biochem 1984; 145: 659- 76.
  • 5Lonnerdal B, lyer S. Lactoferrin: molecular structure and biological function, Annu Rev Nutr 1995; 15: 93-110.
  • 6Ward PP, Paz E, Conneely OM. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 2005; 62: 2540-8.
  • 7Tomita M, Wakabayashi H, Shin K, Yamauchi K, Yaeshima T, Iwatsuki K. Twenty-five years of research on bovine lactoferrin applications. Biochimie 2009; 91: 52-7.
  • 8Cornish J, Callon KE, Naot D, Palmano KP, Banovic T, Bava U, et al. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 2004; 145: 4366-74.
  • 9Grey A, Banovic T, Zhu Q, Watson M, Callon K, Palmano K, et al. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol Endocrinol 2004; 18: 2268-78.
  • 10Grey A, Zhu Q, Watson M, Callon K, Cornish J. Lactoferrin potently inhibits osteoblast apoptosis, via an LRPl-independent pathway. Mol Cell Endocrinol 2006; 251: 96-102.

共引文献36

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部